A 58-year-old man with a history of hypertension and left ventricular hypertrophy presents with palpitations. ECG shows atrial fibrillation with a ventricular rate of 120 bpm. He is started on intravenous amiodarone for rate control and rhythm conversion. Which of the following best explains the antiarrhythmic mechanism of amiodarone in this clinical scenario?

Explanation

## Amiodarone's Antiarrhythmic Mechanism ### Classification and Primary Action **Key Point:** Amiodarone is a Class III antiarrhythmic agent, and its **dominant mechanism** in treating atrial fibrillation is potassium channel blockade, which prolongs the action potential duration (APD) and refractory period. ### Mechanism of Action in Atrial Fibrillation Amiodarone blocks cardiac potassium channels (particularly IK and IKr), leading to: 1. **Prolongation of the action potential duration** — the repolarization phase is extended 2. **Increased refractory period** — atrial tissue remains refractory for longer, reducing the ability of re-entrant circuits to sustain arrhythmias 3. **Suppression of re-entry** — by lengthening refractoriness, amiodarone breaks the cycle of re-entrant atrial fibrillation, which is the primary mechanism in this patient ### Why Amiodarone Works in This Case Atrial fibrillation is typically driven by **re-entrant circuits** within the atria. By prolonging the refractory period via potassium channel blockade, amiodarone: - Prevents premature atrial depolarizations from re-entering tissue that has just recovered excitability - Allows the AV node time to recover between atrial impulses, slowing ventricular rate - Promotes rhythm conversion by eliminating the substrate for re-entry **Clinical Pearl:** Although amiodarone has **all four classes** of antiarrhythmic properties (Class I, II, III, and IV), its **Class III effect (potassium channel blockade)** is the most prominent and clinically important for arrhythmia suppression, particularly in atrial fibrillation. ### Why Other Options Are Secondary While amiodarone does possess: - **Class I activity** (sodium channel blockade) — slows conduction but is not the dominant effect - **Class II activity** (beta-blockade) — reduces automaticity but is minor - **Class IV activity** (calcium channel blockade) — slows AV nodal conduction but is not primary These properties are **adjunctive** to its Class III mechanism. **High-Yield:** On NEET PG exams, when asked about amiodarone's mechanism in atrial fibrillation, always select **potassium channel blockade and APD prolongation** as the primary answer. [cite:KD Tripathi 8e Ch 35]